Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul W A Janssen

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal of Cardiovascular Translational Research|April 2, 2013
Platelet function testing and tailored antiplatelet therapyPaul W A Janssen, Jurriën M ten Berg
JACC. Cardiovascular Interventions|March 7, 2020
Personalized P2Y<sub>12</sub> Inhibitor Treatment: Are We Ready to Go?Jurriën M Ten Berg, Paul W A Janssen
Current Opinion in Cardiology|June 8, 2015
Antithrombotic therapy in the anticoagulated patient undergoing percutaneous coronary intervention with coronary stentingDarshni A Jhagroe, Paul W A Janssen, Jurrien M Ten Berg
Blood Reviews|April 22, 2014
The use of platelet function testing in PCI and CABG patientsPaul W A Janssen, Jurriën M ten Berg, Christian M Hackeng
Thrombosis and Haemostasis|July 17, 2015
The effect of acenocoumarol on the antiplatelet effect of clopidogrelWillem J M Dewilde, Paul W A Janssen, Thomas O Bergmeijer, et al.
Journal of the American College of Cardiology|September 20, 2014
Triple therapy for atrial fibrillation and percutaneous coronary intervention: a contemporary reviewWillem J M Dewilde, Paul W A Janssen, Freek W A Verheugt, et al.
Journal of the American College of Cardiology|February 10, 2015
Reply: Triple therapy for atrial fibrillation and ACS with or without PCI: don't drop aspirin just yetWillem J M Dewilde, Paul W A Janssen, Freek W A Verheugt, et al.
Seminars in Thrombosis and Hemostasis|June 1, 2017
How Long Does It Take for Clopidogrel and Ticagrelor to Inhibit Platelets in Patients Undergoing Primary Percutaneous Coronary Intervention? A Detailed Pharmacodynamic Analysis: Time Course of Platelet Reactivity in STEMI (TOPS)Thomas O Bergmeijer, Thea C Godschalk, Paul W A Janssen, et al.
Vascular Pharmacology|January 3, 2016
The use of platelet reactivity testing in patients on antiplatelet therapy for prediction of bleeding events after cardiac surgeryTesse C Leunissen, Paul W A Janssen, Jurriën M Ten Berg, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Safety of Ticagrelor Compared to Clopidogrel after Prehospital Initiation of TreatmentThomas O Bergmeijer, Mathijs van Oevelen, Paul W A Janssen, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of Cardiovascular Translational Research|April 2, 2013
Platelet function testing and tailored antiplatelet therapyPaul W A Janssen, Jurriën M ten Berg
JACC. Cardiovascular Interventions|March 7, 2020
Personalized P2Y<sub>12</sub> Inhibitor Treatment: Are We Ready to Go?Jurriën M Ten Berg, Paul W A Janssen
Current Opinion in Cardiology|June 8, 2015
Antithrombotic therapy in the anticoagulated patient undergoing percutaneous coronary intervention with coronary stentingDarshni A Jhagroe, Paul W A Janssen, Jurrien M Ten Berg
Blood Reviews|April 22, 2014
The use of platelet function testing in PCI and CABG patientsPaul W A Janssen, Jurriën M ten Berg, Christian M Hackeng
Thrombosis and Haemostasis|July 17, 2015
The effect of acenocoumarol on the antiplatelet effect of clopidogrelWillem J M Dewilde, Paul W A Janssen, Thomas O Bergmeijer, et al.
Journal of the American College of Cardiology|September 20, 2014
Triple therapy for atrial fibrillation and percutaneous coronary intervention: a contemporary reviewWillem J M Dewilde, Paul W A Janssen, Freek W A Verheugt, et al.
Journal of the American College of Cardiology|February 10, 2015
Reply: Triple therapy for atrial fibrillation and ACS with or without PCI: don't drop aspirin just yetWillem J M Dewilde, Paul W A Janssen, Freek W A Verheugt, et al.
Seminars in Thrombosis and Hemostasis|June 1, 2017
How Long Does It Take for Clopidogrel and Ticagrelor to Inhibit Platelets in Patients Undergoing Primary Percutaneous Coronary Intervention? A Detailed Pharmacodynamic Analysis: Time Course of Platelet Reactivity in STEMI (TOPS)Thomas O Bergmeijer, Thea C Godschalk, Paul W A Janssen, et al.
Vascular Pharmacology|January 3, 2016
The use of platelet reactivity testing in patients on antiplatelet therapy for prediction of bleeding events after cardiac surgeryTesse C Leunissen, Paul W A Janssen, Jurriën M Ten Berg, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Safety of Ticagrelor Compared to Clopidogrel after Prehospital Initiation of TreatmentThomas O Bergmeijer, Mathijs van Oevelen, Paul W A Janssen, et al.
Pageof 3